Study guide

5.1 Disciplinary Grounds (CGS § 20-579)

Connecticut Multistate Pharmacy Jurisprudence Examination CT MPJE

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 About the Connecticut MPJE 1.2 Application, Fees, ATT, and Pearson VUE 1.3 Blueprint, Scoring, Retakes, and Study Strategy

2 Connecticut Regulatory Structure

2.1 DCP and the Commission of Pharmacy 2.2 Chapter 400j, 420b/420c, and RCSA 20-576 2.3 Federal vs Connecticut Law (More Restrictive Rule)

3 Pharmacist Licensure, Interns, PIC, and CE

3.1 Pharmacist Qualifications and Exam Path 3.2 Interns, Score Transfer, and Reciprocity 3.3 Pharmacist-in-Charge / Pharmacist Manager 3.4 License Renewal and Continuing Education

4 Technicians and Non-Pharmacist Personnel

4.1 Technician Registration and Certification 4.2 Community Technician Ratios (20-576-36) 4.3 Institutional Ratios and Advanced Pharmacy Technicians 4.4 Technician Limitations, Interns, and Unlicensed Staff

5 Discipline, Impairment, and Unlicensed Practice

5.1 Disciplinary Grounds (CGS § 20-579) 5.2 Impaired Practitioner Reporting and Programs 5.3 Unlicensed Practice, Penalties, and Appeals

6 Federal Drug Law Foundations

6.1 FDCA, Adulteration, and Misbranding 6.2 FDA Approval, Recalls, and OTC vs Rx 6.3 DSCSA, HIPAA, OBRA ’90, and PPPA

7 Federal Controlled Substances

7.1 CSA Schedules and Definitions 7.2 DEA Registration and Forms 222, 106, 41 7.3 Federal Controlled-Substance Prescription Rules 7.4 Inventory, Theft, Loss, and Disposal

8 Prescription Issuance in Connecticut

8.1 Who May Prescribe in Connecticut 8.2 Noncontrolled Prescription Form and Content 8.3 Controlled Prescriptions and the EPCS Mandate

9 Refills, Partial Fills, and Opioid Limits

9.1 Refill Authority (Noncontrolled and CIII–V) 9.2 Partial Fills of Schedule II Prescriptions 9.3 Connecticut Opioid Supply Limits (7-day / 5-day)

10 Administration, CDTM, and Standing Orders

10.1 Pharmacist Immunization Authority 10.2 Collaborative Drug Therapy Management 10.3 Naloxone and Opioid Antagonist Access 10.4 Emergency and Hormonal Contraception

11 Counseling, Confidentiality, and Returns

11.1 Counseling and Offer to Counsel 11.2 HIPAA and Connecticut Confidentiality 11.3 Return, Reuse, and Take-Back

12 Corresponding Responsibility and DUR

12.1 Corresponding Responsibility and Legitimate Medical Purpose 12.2 Prospective Drug Utilization Review 12.3 Exceptions and Conditions Prohibiting Dispensing

13 Transfers, Labeling, Packaging, and Delivery

13.1 Transferring Prescriptions 13.2 Labeling of Dispensed Drugs 13.3 Packaging and the Poison Prevention Packaging Act 13.4 Delivery of Drugs

14 CPMRS, Substitution, and Nonprescription Drugs

14.1 CPMRS Query and Reporting 14.2 Generic and Biosimilar Substitution 14.3 CMEA and Behind-the-Counter Products 14.4 OTC Labeling, Hazardous, and Restricted Nonprescription Drugs

15 Ordering, Records, and Inventories

15.1 Ordering and Acquisition (DEA 222/CSOS) 15.2 Distribution and DSCSA Records 15.3 Recordkeeping Content and Three-Year Retention 15.4 Controlled-Substance Inventories and CT Perpetual CII

16 Storage, Security, and Hazardous Drugs

16.1 Controlled-Substance Storage and Security 16.2 Hazardous Drugs (USP <800>, NIOSH) 16.3 Non-Pharmacist Access to Drugs

17 Compounding and Central Fill

17.1 Nonsterile Compounding (USP <795>, RCSA 20-576-69) 17.2 Sterile Compounding (USP <797>, RCSA 20-576-64) 17.3 Central Fill, 503A, and 503B Outsourcing

18 Pharmacy Permits and Practice Settings

18.1 Pharmacy License, Hours, Manager, and Signage 18.2 Nonresident, Hospital, Nuclear, and Automated Dispensing 18.3 Inspection, Closure, and Facility Discipline

5.1 Disciplinary Grounds (CGS § 20-579)

Key Takeaways Explain This Topic AI

CGS § 20-579(a) lets the Commission refuse to issue or renew, revoke, suspend, or place conditions on a pharmacist license, temporary permit, pharmacy license, intern registration, or technician registration, and assess a civil penalty of up to $1,000 per violation of Chapter 400j.

Section 20-579(a) currently lists 21 numbered grounds, including out-of-state discipline, illegal diversion, alcohol or drug abuse, false statements, CE falsification, aiding unlicensed practice, and USP <795>/<797> failures; P.A. 82-419 removed a generic “unprofessional conduct” catch-all.

CGS § 20-579(b) is a separate impairment track: a physical, mental, or substance-use condition that would interfere with practice can support the same license actions, limited by CGS § 46a-73 and the ADA (42 USC § 12132).

CGS § 20-579a (2026 supplement, effective July 1, 2025) bars DCP and the Commission from denying eligibility or imposing discipline based solely on another jurisdiction’s action that is only about reproductive or gender-affirming health care that is legal in Connecticut and met the standard of care.

DCP investigates complaints under CGS § 21a-8; Commission hearings follow UAPA Chapter 54; an adverse Commission action is a proposed final decision that the Commissioner of Consumer Protection must approve, modify, or reject under CGS § 21a-7(a)(1).

Last updated: August 2026

Why § 20-579 is an MPJE workhorse

NABP Area 1.2.2 tests grounds for discipline and the sanctions a board may impose. In Connecticut the board is the Commission of Pharmacy , housed in the Department of Consumer Protection (DCP) . Candidates lose items by importing another state’s “unprofessional conduct” catch-all, by treating every violation as an automatic revocation, or by assuming a civil penalty of “whatever the board wants.” CGS § 20-579 is the list. Open it, then overlay § 20-579a , then overlay the UAPA hearing path in CGS §§ 21a-7, 21a-8, and 21a-9 .

Quick Answer: The Commission may refuse a temporary permit, refuse to issue or renew a pharmacist license, pharmacy license, intern registration, or technician registration, revoke, suspend, or place conditions , assess a civil penalty of up to $1,000 per violation of Chapter 400j, or take other action listed in CGS § 21a-7(7) —if a § 20-579(a) ground is met or a § 20-579(b) impairing condition is found. Discipline is discretionary (“may”), not mandatory revocation. § 20-579a is a Connecticut-specific bar on using another state’s reproductive-care or gender-affirming-care case as the sole basis for a Connecticut denial or sanction.

Who can be hit, and with what

The same sanction menu applies to five credentials : a temporary permit to practice pharmacy, a license to practice pharmacy , a license to operate a pharmacy , a pharmacy intern registration , and a pharmacy technician registration . Clerks registered under § 20-602 are not named in § 20-579; do not invent a clerk-discipline subdivision.

  • Sanction the Commission may impose Where it lives
  • Refuse to authorize issuance of a temporary permit CGS § 20-579(a), (b)

Refuse to authorize issuance or renewal of a pharmacist license, pharmacy license, intern registration, or technician registration § 20-579(a), (b)

  • Revoke, suspend, or place conditions on those credentials § 20-579(a), (b)
  • Assess a civil penalty of up to $1,000 per violation of any provision of Chapter 400j § 20-579(a) (P.A. 18-16)

Other action under § 21a-7(7) : letter of reprimand , probation (regular reports, practice limits, or additional education), or a fine not exceeding $1,000 per violation CGS § 21a-7(7)

§ 21a-7(7) also lets the Commission discontinue, suspend, or rescind an action it has already taken. A consent order or a stayed suspension with CE and random drug screens is a conditions / probation outcome, not a secret extra statute.

The 21 grounds in CGS § 20-579(a)

Memorize that the Commission acts if the applicant or holder :

Has violated a statute or regulation relating to drugs, devices, or the practice of pharmacy of Connecticut, any U.S. state, the United States, D.C., Puerto Rico, a U.S. territory, or a foreign jurisdiction .

Has been convicted of violating any criminal statute relating to drugs, devices, or the practice of pharmacy of those same jurisdictions.

Has been disciplined by , or is the subject of pending disciplinary action or an unresolved complaint before, a duly authorized pharmacy disciplinary agency of those jurisdictions.

Has been refused a license or registration or renewal by those jurisdictions on grounds similar to grounds Connecticut could use.

Has illegally possessed, diverted, sold, or dispensed drugs or devices.

Abuses or excessively uses drugs, including alcohol .

Has made false, misleading, or deceptive representations to the public or the Commission.

Has maintained exclusive telephone lines , exclusive electronic communication , or exclusive computer access in offices of prescribing practitioners, nursing homes, clinics, hospitals, or other health care facilities.

Has substituted drugs or devices except as permitted in CGS § 20-619 .

Has accepted, for return to regular stock , any drug already dispensed in good faith or delivered from a pharmacy and exposed to possible and uncontrolled contamination or substitution .

Has accepted, for return to general inventory or regular stock , any drug sold or delivered to a patient , unless return is otherwise permitted or required by law (added by P.A. 24-73 ).

Has split fees for professional services, including a discount or rebate, with a prescribing practitioner or an administrator or owner of a nursing home, hospital, or other health care facility.

Has entered an agreement with those same persons for compounding or dispensing secret-formula or coded prescriptions .

Has performed or been a party to a fraudulent or deceitful practice or transaction .

Has presented to the Commission a diploma, license, or certificate illegally or fraudulently obtained , or obtained from a college or school of pharmacy not approved by the Commission .

Has performed incompetent or negligent work .

Has falsified a continuing education document submitted to the Commission or department, or a certificate retained under CGS § 20-600(d) .

Has permitted a person not licensed to practice pharmacy in this state to practice pharmacy in violation of § 20-605 , to use a pharmacist license or pharmacy display document in violation of § 20-608 , or to use words, displays, or symbols in violation of § 20-609 .

Has failed to maintain the entire pharmacy premises , components, and contents in a clean, orderly, and sanitary condition.

Has failed to demonstrate adherence to applicable USP <797> (sterile compounding).

Has failed to demonstrate adherence to applicable USP <795> (nonsterile compounding).

Do not teach a current “unprofessional conduct” bullet. P.A. 82-419 deleted crimes of moral turpitude, lack of professional integrity, and unprofessional conduct as free-standing grounds. If the stem says “unprofessional conduct” with no matching subdivision, look for incompetent or negligent work , fraud , false representations , or a specific statute/regulation violation instead.

Impairment as a separate subsection — § 20-579(b)

Subsection (b) is not one of the 21 numbered grounds. It is a parallel track . The Commission may impose the same refuse / revoke / suspend / condition package (and other § 21a-7(7) action) if the applicant or holder has a condition —including, but not limited to , physical illness or loss of skill or deterioration due to aging, emotional disorder or mental illness, or abuse or excessive use of drugs or alcohol —that would interfere with practicing pharmacy, operating a pharmacy, or acting as an intern or technician.

Two civil-rights limits are written into the same sentence: the Commission may not , in taking action on the basis of such a condition, violate CGS § 46a-73 (Connecticut’s public-accommodation / state-services disability rule) or 42 USC § 12132 of the Americans with Disabilities Act . Impairment discipline is about current interference with safe practice , not a diagnosis standing alone. Confidential assistance-program diversion of that file is Chapter 5.2 ( §§ 20-638 to 20-638c ).

The reproductive and gender-affirming overlay — § 20-579a

CGS § 20-579a is a current Connecticut-specific override of the usual “sister-state discipline” grounds in § 20-579(a)(3) and (4). The 2025 official publication covered reproductive health care services . The 2026 supplement (P.A. 25-168, effective July 1, 2025 ) added gender-affirming health care services , both as defined in CGS § 52-571m .

Notwithstanding any provision of Chapter 400j , the Commissioner of Consumer Protection and the Commission of Pharmacy shall not :

  • deny eligibility of an applicant for a license, permit, or registration, or
  • impose disciplinary action against a person already licensed, permitted, or registered,

based on pending discipline, an unresolved complaint, or imposed discipline by another U.S. jurisdiction that is based solely on alleged provision of, receipt of, assistance in, material support for, or vicarious/joint/conspiracy liability derived from, reproductive health care services or gender-affirming health care services that are permitted under Connecticut law and were provided in accordance with the applicable standard of care , whether or not the patient was a Connecticut resident .

The overlay does not apply if the underlying conduct would itself be a Connecticut disciplinary ground if it had occurred in Connecticut (for example, incompetent compounding, diversion, or a sterile-product USP failure dressed up as a “care” case). Teach the overlay as a shield against out-of-state political prosecutions of care that Connecticut allows , not as immunity for malpractice or drug-law violations.

Process: complaint, investigation, notice, hearing

CGS § 20-575 gives the Commission administration, subpoena, and injunctive powers over the Pharmacy Practice Act. CGS § 21a-8(8) is the intake pipe: DCP receives complaints , screens out allegations that would not be a violation even if true, investigates the rest, and the commissioner may dismiss for lack of probable cause or bring the complaint to the Commission for a formal hearing if probable cause exists. Board members who helped investigate do not sit on the resulting disciplinary hearing.

Hearings run under UAPA Chapter 54 and the commissioner’s uniform rules of procedure in CGS § 21a-9 . CGS § 21a-7(a)(3) lets the Commission administer oaths, subpoena, and compel records. CGS § 21a-7(a)(1) is the Connecticut twist many candidates miss: except for Liquor Control, any exercise of Commission functions adverse to a party is a proposed final decision subject to approval, modification, or rejection by the Commissioner of Consumer Protection . The Commission does not personally mail a final revocation that bypasses the commissioner.

CGS § 20-638b(i) (impairment petitions) restates the due-process floor that applies more broadly under CGS § 4-182 : DCP shall not restrict, suspend, or revoke, or limit the right to practice, until the pharmacist or intern has been given notice and opportunity for hearing .

Realistic Connecticut scenarios

A Waterbury pharmacist attests at renewal that 15 contact hours , including five live hours and one hour of pharmacy law , were completed in the prior calendar year, and files a CE certificate that invents a live law program the pharmacist never attended. That is § 20-579(a)(17) (falsified CE document or § 20-600(d) certificate) and usually also (7) (false representations to the Commission) and (14) (fraudulent practice). “I was too busy, but I meant to finish the hours” is not a defense to falsification . Missing hours without a false document is a § 20-600 renewal problem; lying about the hours is a § 20-579 ground.

A reciprocity applicant discloses a Georgia board reprimand that, on the papers, is only for assisting a patient with medication abortion care that is lawful in Connecticut and that met the standard of care. § 20-579(a)(3) would otherwise be in play. § 20-579a tells DCP and the Commission they shall not deny the Connecticut application based solely on that Georgia file. If Georgia also found CII diversion , the diversion is still a Connecticut ground.

Official anchors

CGS Chapter 400j (2025 publication) — §§ 20-575, 20-579, 20-579a.

2026 supplement to Chapter 400j — § 20-579a as amended by P.A. 25-168 (gender-affirming care).

CGS §§ 21a-7, 21a-8, 21a-9 — Commission powers, DCP investigation, UAPA hearings, $1,000 fine / reprimand / probation menu.